BioCentury
ARTICLE | Company News

Acambis, Swiss Serum & Vaccine Institute deal

March 19, 2001 8:00 AM UTC

ACM and the Institute will develop a single dose oral combination typhoid and cholera vaccine. The parties will share costs of the remaining clinical trials and the institute will fund process develop...